transfusing wisely webinar
Published 1 year ago • 457 plays • Length 1:01:55Download video MP4
Download video MP3
Similar videos
-
0:20
beta-lactamase: destroying antibiotic
-
27:26
inflammation in residual risk.
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
1:04:55
non-conventional combination-based strategies to combat antimicrobial resistance
-
22:20
antiplatelet theraphy in cvd prevention
-
1:22:35
the fight against antimicrobial resistance: a luta continua
-
55:50
target selectivity of multispecific antibodies: practical analysis of binding kinetics and avidity
-
1:38:04
chemical reviews thematic talk series: gold chemistry
-
2:19
evaluating anti-cd32b f(ab) conformation
-
26:11
carbapenem resistant enterobacterales (cre) treatment: do multinational observational studies help?
-
1:11
3_3 will vaccines be able to eliminate or eradicate covid-19?
-
3:39
cd3 proteins: hot target for bispecific antibody
-
4:48
mirna-506-3p directly regulates rs10754339 (a/g) in immune checkpoint protein b7-h4 in breast cancer
-
54:24
controversy: dual vs triple antithrombotic therapy in af patients undergoing pci. what’s best?
-
7:09
hormonal regulation of acid base balance
-
5:58
pharmacology - immune checkpoint inhibitors in cancer immunotherapy
-
1:33
q3 - reducing ci-aki incidence in tavr procedures
-
2:02
alnuctamab, a bcma x cd3 tce, in the treatment of multiple myeloma
-
1:42
dose escalation of ro7283420, a hla-a2-wt1 cd3 t-cell bispecific antibody, in r/r aml
-
18:14
disorders of fatty acid oxidation (3 of 3)
-
0:54
rna targeting medicines search and delete in cells p3
-
26:24
intensive care bundle with blood pressure reduction in acute cerebral hemorrhage: the interact3 t...